Characteristics | ID (n = 206) | NIS (n = 653) | p-Value |
---|---|---|---|
Mothers | |||
 Age at delivery (years) | 29.26 ± 5.08 | 29.00 ± 5.27 | 0.526 |
 Gestational age (wk) | 39.40 ± 1.97 | 39.35 ± 2.03 | 0.737 |
 In the third trimester of pregnancy | |||
 Hb (g/L) | 126.08 ± 12.52 | 110.54 ± 5.97 | 0.001 |
 LGFBG (mmol/L)* | 0.66 ± 0.57 | 0.66 ± 0.57 | 0.551 |
 Pre-pregnancy BMI (kg/m2) | 22.57 ± 1.48 | 22.79 ± 1.53 | 0.076 |
SES | Â | Â | 0.016 |
 Low | 243 (37.2) | 55 (26.7) |  |
 Moderate | 226 (34.6) | 78 (37.9) |  |
 High | 184 (28.2) | 73 (35.4) |  |
 Extra-sport activities during pregnancy | 288 (44.1) | 89 (43.2) | 0.820 |
 Pre-pregnancy smoking | 4 (1.5) | 3 (0.6) | 0.368 |
 Passive smoking during pregnancy | 145 (22.2) | 51 (24.8) | 0.447 |
 Pre-pregnancy drinking | 65 (10.0) | 19 (9.2) | 0.758 |
 Dietary pattern |  |  | 0.875 |
 Vegetarian diet | 147 (22.5) | 42 (20.4) |  |
 Meat diet | 210 (32.2) | 70 (34.0) |  |
 Mixed diet | 296 (45.3) | 94 (45.6) |  |
 Cesarean delivery | 281 (43.0) | 80 (38.8) | 0.287 |
 Assisted reproductive technology | 44 (6.7) | 15 (7.3) | 0.788 |
 Hypertension during pregnancy | 24 (3.7) | 6 (2.9) | 0.603 |
Newborns | |||
 Heel prick blood SF (ng/mL) | 87.65 ± 27.27 | 94.42 ± 17.74 | 0.001 |
 Birth weight (g) | 3495.70 ± 271.97 | 3479.47 ± 277.67 | 0.458 |
 Apgar score at 5 min | 9.99 ± 0.14 | 9.99 ± 0.10 | 0.803 |
 Male sex | 400 (61.3) | 124 (60.2) | 0.785 |
Absolute latency (ms) | |||
 Wave I | 1.81 ± 0.30 | 1.78 ± 0.35 | 0.268 |
 Wave III | 4.27 ± 0.61 | 4.26 ± 0.57 | 0.719 |
 Wave V | 5.99 ± 0.84 | 5.81 ± 0.72 | 0.002 |
IPL (ms) | |||
 LG I-III | 0.39 ± 0.07 | 0.39 ± 0.07 | 0.745 |
 LG III-V | 0.35 ± 0.09 | 0.33 ± 0.07 | 0.001 |
 LG I-V | 0.67 ± 0.07 | 0.66 ± 0.07 | 0.133 |
 SP/AP ratio (wave III) | 27.13 ± 4.10 | 26.62 ± 4.08 | 0.118 |
 SP/AP ratio (wave V) | 27.99 ± 4.41 | 26.98 ± 3.76 | 0.003 |
Childrena | |||
 COVID-19 | 185 (97.4) | 578 (98.5) | 0.323 |
 OME |  |  | 0.019 |
 No | 178 (94.7) | 517 (88.7) |  |
 After COVID-19 | 6 (3.2) | 53 (9.1) |  |
 Before COVID-19 | 4 (2.1) | 13 (2.2) |  |